CUSIP: 586858102
Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
34,654,915
-
Share change
-
+20,794,500
-
Total reported value
-
$92,541,279
-
Put/Call ratio
-
110%
-
Price per share
-
$2.68
-
Number of holders
-
90
-
Value change
-
+$45,559,007
-
Number of buys
-
75
-
Number of sells
-
18
Quarterly Holders Quick Answers
What is CUSIP 586858102?
CUSIP 586858102 identifies MNLO - MENLO THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2020
-
Previous quarter:
Q4 2019
Recent filing periods for CUSIP 586858102:
Institutional Holders of MENLO THERAPEUTICS INC - COM (MNLO) as of Q1 2020
As of 31 Mar 2020,
MENLO THERAPEUTICS INC - COM (MNLO) was held by
90 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,654,915 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Vivo Capital, LLC, BlackRock Inc., DSC Advisors, L.P., 683 Capital Management, LLC, ORBIMED ADVISORS LLC, GREAT POINT PARTNERS LLC, venBio Partners LLC, MANGROVE PARTNERS, and VANGUARD GROUP INC.
This page lists
90
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.